Naproxeno Teva-Ratiopharm (Naproxen)

Naproxen blocks the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, the drug diminishes the inflammatory cascade, reduces pain signal transmission, and helps lower elevated body temperature.

The specific dosage and regimen of Naproxeno Teva-Ratiopharm are determined by a qualified prescriber based on the patient’s condition, severity, age, and renal or hepatic function. Healthcare professionals tailor the dose to achieve optimal therapeutic effect while minimizing risk.

Naproxen is generally classified as a pregnancy category that should be avoided, especially in the third trimester, due to potential fetal cardiovascular effects. It is also excreted in breast milk, so breastfeeding mothers should consult their physician before using naproxen.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naproxen has a longer half‑life than ibuprofen, allowing for less frequent dosing. Both share similar mechanisms of COX inhibition, but naproxen may carry a slightly higher risk of gastrointestinal irritation, while ibuprofen is often preferred for short‑term use. Choice depends on clinical judgment and patient tolerance.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and light. Do not refrigerate or freeze the tablets, and keep them out of reach of children.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should follow the prescriber’s instructions regarding timing and frequency.

Serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, and acute kidney injury. Patients should seek immediate medical attention if they notice signs of bleeding, chest pain, rash, or sudden loss of kidney function.

Individuals with a known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment should avoid using this product. A healthcare professional should evaluate suitability before prescribing.